Apnimed

Public

Cambridge, MassachusettsBiotechhttps://apnimed.com/

Apnimed is now publicly traded

The data on this page reflects Apnimed's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Jul 31, 2026

Last Round

Debt

Mar 27, 2026

Total Funding Raised

$558.8M

Company Overview

Apnimed is a pharmaceutical company that develops novel oral therapies for the treatment of obstructive sleep apnea and other sleep-related breathing diseases.

Sector

Biotech

Verticals

HealthTech, Life Sciences, LOHAS & Wellness

AI Layer

Non-AI

Keywords

obstructive sleep apneaOSAsleep apnea pilloral pharmacologic therapyAD109sleep apnea treatmentclinical-stage biopharmanew drug applicationNDACPAP alternativeairway patencybiopharmaceutical developersleep medicinenon-invasive therapy

Apnimed Comparables

Compare Apnimed with similar companies based on industry and business-model similarity.

Apnimed comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Mosanna Therapeutics	80%
Shionogi & Co.	78%
Incannex Healthcare Inc.	78%

View all Comparables

Apnimed Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO	Jul 31, 2026
Debt	Mar 27, 2026
Convertible Debt	Sep 17, 2025
IPO	Jun 6, 2025
Series C Extension	Jan 3, 2023
Series C	May 4, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Mike Kelly

Chief Financial Officer

Executive Team

Luigi Taranto Montemurro

Chief Scientific Officer

Executive Team

Apnimed Investors

Notable investors and investment history

Apnimed investors
Investor	Rounds
Evercore ISI	IPO
Ameriprise Financial	Series B
HealthCare Royalty Partners	Debt
Columbia Threadneedle Investments	Series C, Series C Extension
Morningside Ventures	Series A, Series C, Series B
J. & W. Seligman & Company	Series C, Series B
Sectoral	Series C, Series C Extension

View all Investors

Apnimed Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Apnimed Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range95

Year Founded2017

Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?